Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/22/25 21:00 | 1/22/24 | DTIL | Health | BioPrd | Biological Products, (No Diag | Scimeca Dario | NC | O | GC,Secre | 6 | S.d | -66 | 1.39 | 0 | -47 | 151 | D | |||||||||||||||
1/22/25 21:00 | 1/22/24 | DTIL | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | 5 | S.d | -312 | 1.03 | 0 | -304 | 356 | D | |||||||||||||||
1/22/25 21:00 | 1/23/24 | DTIL | Health | BioPrd | Biological Products, (No Diag | Smith J. Jefferson | NC | O | Chief Re | 4 | S.d | -62 | 1.61 | 0 | -38 | 2,225 | D | |||||||||||||||
5/3/24 18:30 | 1/22/24 | DTIL | Health | BioPrd | Biological Products, (No Diag | List Alan | NC | O | Chief Me | 3 | S.d | -13 | 0.5953 | 0 | -22 | 95 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |